Patented Technology · FDA 510(k) Submission in Progress
Form 211 Filed · OTC Markets
The first truly compact, vertical hyperbaric chamber designed for physician adoption pending FDA clearance. Fits in a standard 10x10 or 10x12 exam room and delivers on a standard elevator—designed to transform patient outcomes and expand access to advanced care.
Prototype of the RxAir360 Vertical Monoplace Hyperbaric Chamber — currently in premarket testing and pending FDA 510(k) clearance.
RxAir360 brings hyperbaric oxygen therapy out of hospitals and into physician offices—making advanced healing accessible to more patients in familiar, convenient settings.
Revolutionary vertical chamber fits in a typical exam room (10x10 or 10x12 footprint) and fits on standard elevators—perfect for multi-story office buildings. No facility remodel or expansion required.
Comfortable, non-intimidating chamber design increases patient acceptance and treatment adherence.
RxAir Capital Solutions offers turnkey leasing options—no large upfront investment needed to get started.
Currently completing FDA 510(k) submission with established regulatory pathway for market entry.
Partnered with proven manufacturers; tooling and scale-up processes already in progress.
Proven revenue model with clear ROI path for physician practices and investor partners.
Our Journey
From engineering breakthrough to market launch—engineered to improve accessibility and transform how physicians deliver hyperbaric therapy.
2023–2025
2025
2026
For informational and investor awareness purposes only. The RxAir360 chamber is not yet cleared for clinical use.
RxAir360 creates value for everyone in the healthcare ecosystem—from physicians building their practice to patients seeking better outcomes to investors seeking meaningful returns.
Prototype — currently in premarket testing, pending FDA 510(k) clearance.
Market Opportunity
Hyperbaric oxygen therapy has been proven effective for wound healing, recovery, and numerous medical conditions—but it's been largely confined to hospitals and specialty centers. RxAir360 changes that.
500,000+
Potential Practice Sites
Millions
Underserved Patients
HBOT is FDA-cleared for wound healing, diabetic ulcers, radiation injury, and other indications
Aging population and rise in chronic conditions driving increased need
Established CPT codes and insurance coverage pathways
Limited Early Access Opportunities
Whether you're a physician looking to expand your services or an investor seeking a high-growth opportunity in medical technology, we'd love to connect.